Skip to main content

Treatment of Severe Aplastic Anemia: A 12-Year Follow-Up of Patients after Bone Marrow Transplantation or after Therapy with Antilymphocyte Globulin

  • Chapter
Aplastic Anemia and Other Bone Marrow Failure Syndromes

Abstract

Of 145 patients with severe aplastic anemia (SAA) treated in Basel from 1976 to January 1988, 34 with HLA identical siblings had bone marrow transplants (BMT) and 111 were treated with antilymphocyte globulin (ALG). We have analyzed the incidence of late complications in both groups of patients. Thirty-two patients treated with ALG developed a hematological complication: 10 of them a myelodysplastic syndrome (MDS) and 18 paroxysmal nocturnal hemoglobinuria (PNH). Twelve of the 18 PNH patients were clinically symptomatic. Two patients had both MDS and PNH and 8 patients of the ALG group had a relapse of SAA. After BMT none of these complications was observed. Most of the nonhematological problems were associated with therapy. In the ALG group, androgens were responsible for impotence and gynecomastia in men and a low voice in women. Four patients developed hepatic tumors. Aseptic necrosis of the hip was seen in 4 patients and one developed breast cancer. The most serious late complication after BMT was chronic graft-versus-host disease (GvHD) in patients receiving methotrexate (MTX) for prophylaxis against GvHD.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bacigalupo A, Gordon-Smith EC, Van Lint MT, Congiu A, Gluckman E, Margiocco M, Ferrari G, De Planque MM, Ernst P, McCann S, Ragavashar A, Nissen C, Würsch A, Salvin S, Hinterberger W, Gmür J, Ringden O, Toivanen A, Marmont AM. Bone marrow transplantation (BMT) vs. immunosuppression (IS) in the management of severe aplastic anemia (SAA). Bone Marrow Transplant 1987; 2 (Suppl 1):99.

    Google Scholar 

  2. Doney K, Storb R, Buckner CD, McGuffin R, Witherspoon R, Deeg HJ, Appelbaum FR, Sullivan KM, Thomas ED. Treatment of aplastic anemia with antithymocyte globulin, high-dose corticosteroids, and androgens. Exp Hematol 1987; 15:239–242.

    PubMed  CAS  Google Scholar 

  3. Gordon-Smith EC. Treatment of aplastic anemia: In: Aplastic Anemia: Stem Cell Biology and Advances in Treatment. New York, Liss, 1984: pp. 335–341.

    Google Scholar 

  4. Speck B, Gratwohl A, Nissen C, Osterwalder B, Würsch A, Tichelli A, Lori A, Reusser P, Jeannet M, Signer E. Treatment of severe aplastic anemia. Exp Hematol 1986; 14:126–132.

    PubMed  CAS  Google Scholar 

  5. Champlin R, Ho W, Bayever E, Winston DJ, Lewarsky C, Feig SA, Gale RP. Treatment of aplastic anemia: Results with bone marrow transplantation, antithymocyte globulin, and a monoclonal anti-T cell antibody. In: Aplastic Anemia: Stem Cell Biology and Advances in Treatment. New York, Liss, 1984: pp. 227–238.

    Google Scholar 

  6. Tichelli A, Gratwohl A, Würsch A, Nissen C, Speck B. Late haematological complications in severe aplastic anaemia. Br J Haematol 1988; 69:413–418.

    Article  PubMed  CAS  Google Scholar 

  7. Speck B, Gratwohl A, Nissen C, Leibundgut U, Ruggero D, Osterwalder B, Burn HP, Cornu P, Jeannet M. Treatment of severe aplastic anemia with antilymphocyte globulin or bone-marrow transplantation. Br Med J 1981; 282:860–863.

    Article  CAS  Google Scholar 

  8. Serke S, Dienemann D, Speck B, Zimmermann T, Baer U, Huhn D. Hepatocellular carcinoma and focal nodular hyperplasia associated with norethandro-lone-therapy: A case report. Blut 1986; 52:111–116.

    Article  PubMed  CAS  Google Scholar 

  9. Tichelli A, Gratwohl A, Speck B, Osterwalder B, Nissen C, Lori A, Würsch A, Walter E, Roth J, Hünig R. Nebenwirkungen der Ganzkörperbestrahlung im Rahmen der Knochenmarktransplantation: Prophylaxe und Therapie. Schweiz Med Wschr 1986; 116:1560–1566.

    PubMed  CAS  Google Scholar 

  10. Gratwohl A, Nissen C, Speck B. Severe aplastic anemia. In Fairbanks VF, ed. Current Hematology 4. New York, Wiley, 1986: pp. 91–121.

    Google Scholar 

  11. Nissen C, Cornu P, Gratwohl A, Speck B. Peripheral blood cells from patients with aplastic anemia in partial remission suppress growth of their own bone marrow precursors in culture. Br J Haematol 1980; 45:233–243.

    Article  PubMed  CAS  Google Scholar 

  12. Anthony PP. Hepatoma associated with androgenic steroids. Lancet 1975; 7908:685–686.

    Article  Google Scholar 

  13. Najean Y, for Joint group for the study of aplastic and refractory anemias. Long-term follow-up in patients with aplastic anemia. Am J Med 1981; 71:543–551.

    CAS  Google Scholar 

  14. Gratwohl A, Speck B. Bone marrow transplantation with cyclosporin. Prog Allergy 1986; 38:404–431.

    PubMed  CAS  Google Scholar 

  15. Gordon-Smith EC, Hows J, Bacigalupo A, GluckmanE, Van Lint MT, Cogin A, James DCO, Barret AJ, De Planque MM, Siimes MA, Toivanen A, Ringden O, Marmont AM. Bone marrow transplantation for severe aplastic anemia (SAA) from donors other than HLA-identical siblings: a report of the EBMT working party. Bone Marrow Transplant 1987; 2 (Suppl 1):100.

    Google Scholar 

  16. Bridges R, Pineo G, Blahey W. Cyclosporin A for the treatment of aplastic anemia refractory to antithymocyte globulin. Am J Hematol 1987; 26:83–87.

    Article  PubMed  CAS  Google Scholar 

  17. Seip M, Vidnes J. Cyclosporin A in a case of refractory severe aplastic anemia. Scand J Hematol 1985; 34:228–230.

    Article  CAS  Google Scholar 

  18. Stryckmans PA, Dumont JP, Velu TH, Debusscher L. Cyclosporin in refractory severe aplastic anemia. N Engl J Med 1984; 310:655–656.

    Article  PubMed  CAS  Google Scholar 

  19. Wisloff F, Godal HC. Cyclosporine in refractory severe aplastic anemia. N Engl J Med 1985; 312:1193.

    PubMed  CAS  Google Scholar 

  20. Camitta BM, Thomas ED. Severe aplastic anemia: a prospective study of the effects of androgens or transplantation on hematological recovery and survival. Clin Hematol 1978; 7:587–594.

    CAS  Google Scholar 

  21. Champlin RE, Ho WG, Feig SA. Do androgens enhance the response to antilymphocyte globulin in patients with aplastic anemia? A prospective randomized trial. Blood 1985; 66:184–188.

    PubMed  CAS  Google Scholar 

  22. Nissen C, De Planque MM, Würsch A, Moser Y, Dalle Carbonare V, Speck B. Testosterone reduces complement sensitivity of precursor cells in aplastic anemia patients treated with antilymphocyte globulin. Br J Haematol 1988; 69:405–411.

    CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Springer-Verlag Inc.

About this chapter

Cite this chapter

Speck, B., Tichelli, A., Gratwohl, A., Nissen, C. (1990). Treatment of Severe Aplastic Anemia: A 12-Year Follow-Up of Patients after Bone Marrow Transplantation or after Therapy with Antilymphocyte Globulin. In: Shahidi, N.T. (eds) Aplastic Anemia and Other Bone Marrow Failure Syndromes. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-3254-4_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-3254-4_8

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4612-7935-8

  • Online ISBN: 978-1-4612-3254-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics